New perspectives into bacterial DNA transfer to human cells

Trends in Microbiology

Volumn 20, Issue 8, 2012, Pages 355-359

  Llosa, Matxalen ^a   Schröder, Gunnar ^b,c   Dehio, Christoph ^b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSITY OF BASEL   (Switzerland)

^c EUROPEAN PATENT OFFICE   (Germany)

Author keywords

Bacterial conjugation; Bartonella; DNA delivery; Gene therapy; R388; Type IV secretion

Indexed keywords

BACTERIAL DNA; BACTERIAL EFFECTOR PROTEIN; BACTERIAL PROTEIN; BACTERIAL VECTOR; DEOXYRIBONUCLEASE; HYBRID PROTEIN; INTEGRASE; PLASMID DNA; TRANSPOSASE; UNCLASSIFIED DRUG; VIRUS VECTOR; ZINC FINGER NUCLEASE;

ANTIGEN PRESENTING CELL; BACTERIAL ARTIFICIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIAL SECRETION SYSTEM; BACTERIUM CONJUGATION; BACTOFECTION; BARTONELLA HENSELAE; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL SPREADING; CELL TYPE; CELL VACUOLE; DNA IMMUNIZATION; DNA INTEGRATION; DNA MODIFICATION; DNA TRANSFER; ENZYME ACTIVITY; EX VIVO STUDY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE INSERTION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN GENOME; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VIVO STUDY; INTRACELLULAR BACTERIUM; LISTERIA; MACROMOLECULE; MAMMAL CELL; MICROBIAL ACTIVITY; MOLECULAR CLONING; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; TRANSGENE; TYPE IV SECRETION SYSTEM; VASCULAR ENDOTHELIUM;

BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; BARTONELLA HENSELAE; BIOLOGICAL TRANSPORT; DNA, BACTERIAL; GENE TRANSFER, HORIZONTAL; HUMANS;

BACTERIA (MICROORGANISMS); BARTONELLA; BARTONELLA HENSELAE;

EID: 84864296504     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.05.008     Document Type: Review

References (35)

1. Waehler R., et al. Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. 2007, 8:573-587.
2. Read M.L., et al. Barriers to gene delivery using synthetic vectors. Adv. Genet. 2005, 53:19-46.
3. Elsabahy M., et al. Non-viral nucleic acid delivery: key challenges and future directions. Curr. Drug Deliv. 2011, 8:235-244.
4. Grillot-Courvalin C., et al. Functional gene transfer from intracellular bacteria to mammalian cells. Nat. Biotechnol. 1998, 16:862-866.
5. Palffy R., et al. Bacteria in gene therapy: bactofection versus alternative gene therapy. Gene Ther. 2006, 13:101-105.
6. Pilgrim S., et al. Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery. Gene Ther. 2003, 10:2036-2045.
7. Moreno M., et al. Salmonella as live trojan horse for vaccine development and cancer gene therapy. Curr. Gene Ther. 2010, 10:56-76.
8. Tangney M., et al. The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy. Bioeng. Bugs 2010, 1:284-287.
9. Pontes D.S., et al. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr. Purif. 2011, 79:165-175.
10. Vassaux G., et al. Bacterial gene therapy strategies. J. Pathol. 2006, 208:290-298.
11. Cheung W., et al. Bacterial delivery of large intact genomic-DNA-containing BACs into mammalian cells. Bioeng. Bugs 2012, 3:86-92.
12. Muhammad A., et al. Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications. Expert. Rev. Vaccines 2012, 11:97-116.
13. McCormack M.P., Rabbitts T.H. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 2004, 350:913-922.
14. Urnov F.D., et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005, 435:646-651.
15. Isalan M. Zinc-finger nucleases: how to play two good hands. Nat. Methods 2011, 9:32-34.
16. Sorrell D.A., Kolb A.F. Targeted modification of mammalian genomes. Biotechnol. Adv. 2005, 23:431-469.
17. Recchia A., Mavilio F. Site-specific integration into the human genome: ready for clinical application?. Rejuvenation Res. 2006, 9:446-449.
18. Fernández-González E., et al. Transfer of R388 derivatives by a pathogenesis-associated type IV secretion system into both bacteria and human cells. J. Bacteriol. 2011, 193:6257-6265.
19. Schröder G., et al. Conjugative DNA transfer into human cells by the VirB/VirD4 type IV secretion system of the bacterial pathogen Bartonella henselae. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14643-14648.
20. Alvarez-Martínez C.E., Christie P.J. Biological diversity of prokaryotic type IV secretion systems. Microbiol. Mol. Biol. Rev. 2009, 73:775-808.
21. Schröder G., Lanka E. The mating pair formation system of conjugative plasmids: a versatile secretion machinery for transfer of proteins and DNA. Plasmid 2005, 54:1-25.
22. Llosa M., et al. Bacterial type IV secretion systems in human disease. Mol. Microbiol. 2009, 73:141-151.
23. Dehio C. Infection-associated type IV secretion systems of Bartonella and their diverse roles in host cell interaction. Cell. Microbiol. 2008, 10:1591-1598.
24. Pulliainen A.T., Dehio C. Persistence of Bartonella spp. stealth pathogens: from subclinical infections to vasoproliferative tumor formation. FEMS Microbiol. Rev. 2012, 36:563-599.
25. Llosa M., et al. Bacterial conjugation: a two-step mechanism for DNA transport. Mol. Microbiol. 2002, 45:1-8.
26. Madzak C., et al. Analysis of single-stranded DNA stability and damage-induced strand loss in mammalian cells using SV40-based shuttle vectors. J. Mol. Biol. 1989, 205:501-509.
27. Mechali M. Eukaryotic DNA replication origins: many choices for appropriate answers. Nat. Rev. Mol. Cell Biol. 2010, 11:728-738.
28. Draper O., et al. Site-specific recombinase and integrase activities of a conjugative relaxase in recipient cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16385-16390.
29. Agúndez L., et al. Site-specific integration of foreign DNA into minimal bacterial and human target sequences mediated by a conjugative relaxase. PLoS ONE 2012, 7:e31047.
30. Agúndez L., et al. Nuclear targeting of a bacterial integrase that mediates site-specific recombination between bacterial and human target sequences. Appl. Environ. Microbiol. 2011, 77:201-210.
31. Gonzalez-Perez B., et al. Changing the recognition site of a conjugative relaxase by rational design. Biotechnol. J. 2009, 4:554-557.
32. Le Provost F., et al. Zinc finger nuclease technology heralds a new era in mammalian transgenesis. Trends Biotechnol. 2010, 28:134-141.
33. Ellis B.L., et al. Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs. Gene Ther. 2012, 10.1038/gt.2011.211.
34. Schulein R., et al. A bipartite signal mediates the transfer of type IV secretion substrates of Bartonella henselae into human cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:856-861.
35. Jafari M., et al. Nonviral approach for targeted nucleic acid delivery. Curr. Med. Chem. 2012, 19:197-208.